These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16326416)

  • 1. Evaluation of anthracycline-induced early left ventricular dysfunction in children with cancer: a comparative study with echocardiography and multigated radionuclide angiography.
    Corapçioglu F; Sarper N; Berk F; Sahin T; Zengin E; Demir H
    Pediatr Hematol Oncol; 2006; 23(1):71-80. PubMed ID: 16326416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are cardiac magnetic resonance imaging and radionuclide ventriculography good options against echocardiography for evaluation of anthracycline induced chronic cardiotoxicity in childhood cancer survivors?
    Basar EZ; Corapcioglu F; Babaoglu K; Anik Y; Gorur Daglioz G; Dedeoglu R
    Pediatr Hematol Oncol; 2014 Apr; 31(3):237-52. PubMed ID: 24499452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered left ventricular longitudinal diastolic function correlates with reduced systolic function immediately after anthracycline chemotherapy.
    Stoodley PW; Richards DA; Boyd A; Hui R; Harnett PR; Meikle SR; Clarke JL; Thomas L
    Eur Heart J Cardiovasc Imaging; 2013 Mar; 14(3):228-34. PubMed ID: 22782955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular systolic reserve in asymptomatic children previously treated with low doses of anthracyclines.
    Guimaraes-Filho F; Tan D; Braga J; Rodrigues A; Waib P; Matsubara B
    Am J Cardiol; 2007 Oct; 100(8):1303-6. PubMed ID: 17920375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late echocardiography assessment of systolic and diastolic function of the left ventricle in pediatric cancer survivors after anthracycline therapy.
    Santin JC; Deheinzelin D; Junior SP; Lopes LF; de Camargo B
    J Pediatr Hematol Oncol; 2007 Nov; 29(11):761-5. PubMed ID: 17984694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radionuclide Methods in the Assessment of Anthracycline-Induced Cardiotoxicity].
    Chernov VI; Kravchuk TL; Zelchan RV; Goldberg VE
    Kardiologiia; 2015; 55(7):57-62. PubMed ID: 26688927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: early and late alterations of left ventricular function during a prospective study.
    Tassan-Mangina S; Codorean D; Metivier M; Costa B; Himberlin C; Jouannaud C; Blaise AM; Elaerts J; Nazeyrollas P
    Eur J Echocardiogr; 2006 Mar; 7(2):141-6. PubMed ID: 15941672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular strain and strain rates are decreased in children with normal fractional shortening after exposure to anthracycline chemotherapy.
    Moon TJ; Miyamoto SD; Younoszai AK; Landeck BF
    Cardiol Young; 2014 Oct; 24(5):854-65. PubMed ID: 24044518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late cardiotoxic effects of anthracycline chemotherapy in childhood malignancies.
    Roodpeyma S; Moussavi F; Kamali Z
    J Pak Med Assoc; 2008 Dec; 58(12):683-7. PubMed ID: 19157322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Echocardiographic evaluation of cardiac function in paediatric oncology patients treated with or without anthracycline.
    Sung RY; Huang GY; Shing MK; Oppenheimer SJ; Li CK; Li CK; Lau J; Yuen MP
    Int J Cardiol; 1997 Aug; 60(3):239-48. PubMed ID: 9261634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of late cardiac toxicity of anthracycline in childhood].
    Butera G; Piciacchia D; Chessa M; Condoluci C; Tornesello A; Delogu AB; Mastrangelo S; Cipriani A
    Minerva Pediatr; 1998 Apr; 50(4):111-9. PubMed ID: 9808963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of left ventricular systolic dysfunction by tissue Doppler imaging to detect subclinical cardiomyopathy early after anthracycline therapy.
    Lotrionte M; Palazzoni G; Natali R; Comerci G; Abbate A; Loperfido F; Biondi-Zoccai G
    Minerva Cardioangiol; 2007 Dec; 55(6):711-20. PubMed ID: 18091640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac dysfunction in cancer survivors unmasked during exercise.
    Kearney MC; Gallop-Evans E; Cockcroft JR; Stöhr EJ; Lee E; Backx K; Haykowsky M; Yousef Z; Shave R
    Eur J Clin Invest; 2017 Mar; 47(3):213-220. PubMed ID: 28036108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison between MUGA and echocardiography in patients with muscular dystrophy in the early detection of cardiac involvement.
    Oğuz D; Olguntürk R; Gücüyener K; Açikgöz GV; Tunaoğlu FS
    Pediatr Cardiol; 1998; 19(2):150-4. PubMed ID: 9565507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients.
    Ganame J; Claus P; Uyttebroeck A; Renard M; D'hooge J; Bijnens B; Sutherland GR; Eyskens B; Mertens L
    J Am Soc Echocardiogr; 2007 Dec; 20(12):1351-8. PubMed ID: 17604960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early prediction of anthracycline cardiomyopathy using standard M-mode and digitized echocardiography.
    Sandor GG; Puterman M; Rogers P; Chan KW; Pritchard S; Popov R
    Am J Pediatr Hematol Oncol; 1992 May; 14(2):151-7. PubMed ID: 1530119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular diastolic filling patterns associated with progressive anthracycline-induced myocardial damage: A prospective study.
    Bu'Lock FA; Mott MG; Oakhill A; Martin RP
    Pediatr Cardiol; 1999; 20(4):252-63. PubMed ID: 10368449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers and early detection of late onset anthracycline-induced cardiotoxicity in children.
    Sherief LM; Kamal AG; Khalek EA; Kamal NM; Soliman AA; Esh AM
    Hematology; 2012 May; 17(3):151-6. PubMed ID: 22664114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA).
    Reuvekamp EJ; Bulten BF; Nieuwenhuis AA; Meekes MR; de Haan AF; Tol J; Maas AH; Elias-Smale SE; de Geus-Oei LF
    J Nucl Cardiol; 2016 Aug; 23(4):824-32. PubMed ID: 26048264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive monitoring of cardiac hemodynamic parameters in doxorubicin-treated patients: comparison with echocardiography.
    Villani F; Meazza R; Materazzo C
    Anticancer Res; 2006; 26(1B):797-801. PubMed ID: 16739356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.